The efficacy and safety of medical therapies assessed on the basis of short-term outcomes are often considered to inform the long-term outcomes. Even in corticosteroid therapy, either systemic or topical, which is most frequently used as a first-line therapy to control inflammation, few studies have reported the risk/benefit ratio for Abbreviations: autoAb, autoantibody; DiHS/DRESS, drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms; HZ, herpes zoster; IMQ, imiquimod; IRIS, immune reconstitution inflammatory syndrome.---